| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. | Nat Genet | 1999 | 2.37 |
| 2 | Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma. | Blood | 1991 | 0.88 |
| 3 | Pharmacokinetics of zileuton and its metabolites in patients with renal impairment. | J Clin Pharmacol | 1997 | 0.76 |
| 4 | Pharmacokinetics of a novel 5-lipoxygenase inhibitor (ABT-761) in pediatric patients with asthma. | Eur J Clin Pharmacol | 1999 | 0.75 |
| 5 | Dose-proportional pharmacokinetics of a new 5-lipoxygenase inhibitor, ABT-761, in healthy volunteers. | Biopharm Drug Dispos | 1998 | 0.75 |
| 6 | Pharmacokinetics and pharmacodynamics of single and multiple oral doses of a novel 5-lipoxygenase inhibitor (ABT-761) in healthy volunteers. | Clin Pharmacol Ther | 1998 | 0.75 |